Elsevier Introduces Technology Intelligence Solution for Accelerating R&D and Innovation in Europe
News Jan 23, 2009
Elsevier has announced the European availability of illumin8, a Web-based natural language processing solution designed to help corporate research professionals answer complex R&D questions with speed and effectiveness.
illumin8 extracts key relationships across the breadth of Elsevier's premium scientific content, millions of patents and 8 billion Web pages and fuses them into an organized view, making it the richest business search solution in the world, Elsevier claims.
illumin8 searches across a wide range of technical and subject domains, serving the needs of research professionals in a number of different fields such as automotive, oil & gas, electronics, chemicals, coatings and consumer goods and packaging.
illlumin8 optimizes Technology Intelligence and discovery practices, enabling users to comprehend key elements of a technology to efficiently deliver on key strategic initiatives. Because of its algorithms, illumin8 is designed to go beyond simple keyword search and is the only tool that can extract relationships from vast amounts of information. It does so by reading and distilling data for actionable insight, such as accelerating product development innovation, identifying new technologies and finding potential partners/collaborators.
XenoGesis and BioAscent Forge Alliance to Offer Enhanced Integrated Drug Discovery ServicesNews
XenoGesis and BioAscent Discovery Limited have announced a collaboration to offer an enhanced range of integrated drug discovery services, including medicinal chemistry, biology and DMPK.READ MORE
BioAscent Establishes Integrated Drug Discovery Services OfferingNews
Dr Phil Jones to join as new CSO to lead company’s extended capabilities in medicinal chemistry and in vitro biosciences.READ MORE
Lab Innovations returns to the NEC, Bimingham , UKNews
Save the date for the UK’s only lab-dedicated exhibition showcase!READ MORE
Comments | 0 ADD COMMENT
International Conference on Biobetters and Regulatory Affairs
Jun 27 - Jun 28, 2018